Research Corner - Biologics or Better Basics? Rethinking Intrabony Defect Healing
Mr Alex Pollard has kindly written a precis of a thought-provoking article that was recently published.
Biologics or Better Basics? Rethinking Intrabony Defect Healing.
This paper by Iorio Siciliano and colleagues felt like a good one to choose for my final Article of the Month, because it demonstrates the balance between careful clinical technique and the promise of biologic adjuncts. The authors looked at whether adding cross linked hyaluronic acid gel to minimally invasive non surgical therapy (MINST) improved outcomes in moderate periodontal intrabony defects.
The study was a single blinded randomised controlled clinical trial involving 42 patients, each contributing one interdental intrabony defect. Patients were allocated to either minimally invasive non surgical therapy alone, or the same treatment with adjunctive cross linked hyaluronic acid gel. The primary outcome was probing depth change, with clinical attachment level, gingival recession, bleeding on probing, pocket closure and radiographic defect fill also assessed. Thirty eight patients completed the 6 month follow up, with no adverse events reported.
Both groups improved substantially. At 6 months, probing depth reduced from 6.7 mm to 4.0 mm in the hyaluronic acid group, and from 6.8 mm to 4.2 mm in the control group. Clinical attachment level also improved in both groups, with a gain of 2.8 mm in the test group and 1.9 mm in the control group. Importantly, although the test group showed better early improvements at 3 months, there was no statistically significant difference between groups for probing depth or clinical attachment level at 6 months.
The pocket closure figures are perhaps the most clinically interesting part. At 3 months, pocket closure was far higher in the hyaluronic acid group, 84.2% compared with 10.5% in the control group. By 6 months, however, the difference had narrowed to 78.9% versus 63.1%, and was no longer statistically significant. This suggests that the adjunct may accelerate early healing, but the longer term clinical advantage appears less clear.
Radiographically, there was a small but statistically significant benefit in favour of the hyaluronic acid group. Defect fill at 6 months was 2.1 mm compared with 1.4 mm in the control group. That is interesting, but I think it needs to be interpreted alongside the clinical findings rather than in isolation. For most patients and clinicians, the key questions remain whether the pocket closes, whether bleeding resolves, and whether the site becomes maintainable.
There are some important limitations. The study was small, with 38 patients completing follow up, and it only ran for 6 months. The patients were selected using strict eligibility criteria, including good oral hygiene and exclusion of heavier smokers and those with systemic disease. There was also no placebo gel, so the operator and patients were not fully masked. The authors acknowledge these points appropriately.
For me, the most useful message is not that hyaluronic acid is ineffective, nor that it should now be used routinely. It is more subtle than that. The adjunct may help early healing and may offer some radiographic benefit, but high quality minimally invasive non surgical therapy alone performed very well. That is probably the most important clinical reminder. Before we reach for additional materials, we should remember the power of excellent instrumentation, good plaque control, careful case selection and time for healing.
As this is my final Article of the Month for the BSP newsletter, it feels fitting to end on a paper that brings us back to the basics. New materials and biologic approaches are exciting, and they absolutely have a place, but they do not replace clinical judgement or technical excellence. In periodontology, as ever, the detail matters.